0L85.L - Sorrento Therapeutics, Inc.

LSE - LSE Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.12
52-week change 3-82.79%
S&P500 52-week change 32.92%
52-week high 33.0550
52-week low 30.0000
50-day moving average 30.3110
200-day moving average 31.2402

Share statistics

Avg vol (3-month) 310.88k
Avg vol (10-day) 315.52k
Shares outstanding 5111.3M
Implied shares outstanding 6N/A
Float 8538.99M
% held by insiders 10.89%
% held by institutions 129.37%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-610.55%

Management effectiveness

Return on assets (ttm)-35.21%
Return on equity (ttm)-1,400.80%

Income statement

Revenue (ttm)60.7M
Revenue per share (ttm)0.13
Quarterly revenue growth (yoy)-11.60%
Gross profit (ttm)-191.84M
EBITDA -357.07M
Net income avi to common (ttm)-671.64M
Diluted EPS (ttm)-1.5270
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)50.32M
Total cash per share (mrq)0.09
Total debt (mrq)169.55M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.44
Book value per share (mrq)-0.23

Cash flow statement

Operating cash flow (ttm)-259.96M
Levered free cash flow (ttm)-128.03M